EUVIMEDEUVIMED entdecken
Crossref

Innovative Treatment Utilizing an Autologous Blood Clot for Diabetic Foot Ulcers

Marie Williams, David Davidson, Naz Wahab, Jessie Hawkins, Chinenye Wachuku, Robert Snyder

Wounds: a compendium of clinical research and practice · 2022 · 34 (7) · 195-200

DOI: 10.25270/wnds/21089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wounds: a compendium of clinical research and practice, 2022. Verfasst von Marie Williams und 5 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diabetic foot ulcer is a complex wound that requires considerable effort to restart a stalled healing process. In this study, a TABCT product was used in a point-of-care setting to treat DFUs by reconstructing the ECM and adjusting intricate phenotypes and mechanisms of mediators to progress towards complete healing. The mechanism of action consists of reconstruction of the ECM, which protects the wound area from further destruction while it incorporates into the ulcer to promote granulation over exposed vital structures (ie, tendons, bone, and neurovascular structures).

Objective

The authors evaluated the efficacy of the TABCT product in the management of DFUs. Materials and Methods. Study participants were wound care patients in hospitals and clinics across the United States and Israel as part of a registry study (ClinicalTrials.gov: NCT04699305). Twenty-nine patients age 18 years or older with chronic DFUs were included. A blood clot was created using the patient’s own peripheral blood in a point-of-care setting. An 18-mL blood sample was drawn from the patient and incorporated with calcium gluconate and kaolin to form a clot. Efficacy and superiority levels in PAR at week 4 and week 12 over the SOC treatment were established using the Agresti-Coull confidence interval.

Results

Treatment of DFUs using the TABCT product resulted in 22 patients (75.86%) achieving 50% PAR at week 4 and showed superiority when compared with SOC data in previously published studies. Complete closure was achieved in 28 wounds (95%) at week 12.

Conclusion

In the current study, TABCT exhibited superiority over SOC treatment and provided granulation over vital structures with a reduction in overall wound size in a timely manner via incorporation and stimulation of the body’s own healing capabilities.

Zitieren

APA

Williams, M., Davidson, D., Wahab, N., Hawkins, J., Wachuku, C., & Snyder, R. (2022). Innovative Treatment Utilizing an Autologous Blood Clot for Diabetic Foot Ulcers. Wounds: a compendium of clinical research and practice, 34(7), 195-200. https://doi.org/10.25270/wnds/21089

Vancouver

Williams M, Davidson D, Wahab N, Hawkins J, Wachuku C, Snyder R. Innovative Treatment Utilizing an Autologous Blood Clot for Diabetic Foot Ulcers. Wounds: a compendium of clinical research and practice. 2022;34(7):195-200. doi:10.25270/wnds/21089

BibTeX
@article{Williams2022,
  author = {Williams, Marie and Davidson, David and Wahab, Naz and Hawkins, Jessie and Wachuku, Chinenye and Snyder, Robert},
  title = {Innovative Treatment Utilizing an Autologous Blood Clot for Diabetic Foot Ulcers},
  journal = {Wounds: a compendium of clinical research and practice},
  year = {2022},
  volume = {34},
  number = {7},
  pages = {195--200},
  doi = {10.25270/wnds/21089}
}
Kostenlos starten →